Unique ID issued by UMIN | UMIN000039697 |
---|---|
Receipt number | R000045275 |
Scientific Title | Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome associated with Oxaliplatin-based Chemotherapy in patients with Gastrointestinal Cancer. |
Date of disclosure of the study information | 2020/03/05 |
Last modified on | 2023/04/03 00:18:03 |
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome associated with Oxaliplatin-based Chemotherapy in patients with Gastrointestinal Cancer.
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome associated with Oxaliplatin-based Chemotherapy in patients with Gastrointestinal Cancer.
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome associated with Oxaliplatin-based Chemotherapy in patients with Gastrointestinal Cancer.
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome associated with Oxaliplatin-based Chemotherapy in patients with Gastrointestinal Cancer.
Japan |
gastrointestinal cancer treated with oxaliplatin-based chemotherapy
Gastroenterology |
Malignancy
NO
We investigate whether US scoring system called HokUS-10 make it possible to early detect SOS/VOD.
Others
We investigate whether HokUS-10 may make it possible to early detect SOS/VOD before the appearance of the increase in spleen volume known as a diagnostic indicator.
Others
The primary endpoint is a probability that a high score of HokUS-10 and the increases in spleen volume of computed tomography are observed in the same case.
The secondary endpoint is a probability that a high score of HokUS-10 and the diagnosis of SOS/VOD based on histopathological findings are observed in the same case.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
The patients with gastrointestinal cancer who are planned to receive scheduled to receive oxaliplatin-based chemotherapy.
1) Patients who have received Oxaliplatin in past treatment.
2) Patients with cirrhosis or chronic hepatitis.
3) Case after liver resection.
4) Case after splenectomy.
30
1st name | Yoshito |
Middle name | |
Last name | Komatsu |
Hokkaido University Hospital
Division of Cancer Center
060-8648
Kita14, Nishi5, Kita-Ku, Sapporo Hokkaido, Japan
0117161161
ykomatsu@med.hokudai.ac.jp
1st name | Rika |
Middle name | |
Last name | Saito |
Hokkaido University Hospital
Division of Cancer Center
060-8648
Kita14, Nishi5, Kita-Ku, Sapporo Hokkaido, Japan
0117161161
lica.saitou@med.hokudai.ac.jp
Hokkaido university hospital
Hokkaido university hospital
Other
Hokkaido University Hospital Clinical Research and Medical Innovation Center
Kita14, Nishi5, Kita-Ku, Sapporo Hokkaido, Japan
0117161161
crjimu@huhp.hokudai.ac.jp
NO
2020 | Year | 03 | Month | 05 | Day |
Unpublished
51
Completed
2019 | Year | 11 | Month | 14 | Day |
2019 | Year | 12 | Month | 11 | Day |
2019 | Year | 12 | Month | 20 | Day |
2022 | Year | 06 | Month | 30 | Day |
HokUS-10 is a scoring system using transabdominal ultrasonography consisting of 10 parameters: hepatomegaly in the (1) left lobe and (2) right lobe, (3) gallbladder wall thickening, (4) portal vein (PV) diameter, (5) paraumbilical vein (PUV) diameter, (6) Amount of ascites, (7) PV mean velocity, (8) Direction of PV flow, (9) Appearance of PUV blood flow signal, (10) hepatic artery resistance-index.
2020 | Year | 03 | Month | 04 | Day |
2023 | Year | 04 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045275